Effect of Influenza on Outcomes in Patients With Heart Failure

JACC: Heart Failure

Volumn 7, Issue 2, 2019, Pages 112-117

  Panhwar, Muhammad S ^a   Kalra, Ankur ^a   Gupta, Tanush ^b   Kolte, Dhaval ^c   Khera, Sahil ^d   Bhatt, Deepak L ^e   Ginwalla, Mahazarin ^a  

^a UNIVERSITY HOSPITALS OF CLEVELAND   (United States)

^b ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

^c MASSACHUSETTS GENERAL HOSPITAL   (United States)

^d Department of Medicine   (United States)

^e BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

heart failure; hospitalization; influenza; vaccination

Indexed keywords

ACUTE KIDNEY FAILURE; ACUTE RESPIRATORY FAILURE; AGE DISTRIBUTION; AGED; ARTICLE; ASSISTED CIRCULATION; CAUCASIAN; CLINICAL OUTCOME; COHORT ANALYSIS; CONTROLLED STUDY; FEMALE; HEALTH CARE COST; HEART FAILURE; HEMODIALYSIS; HIGH RISK POPULATION; HOSPITAL MORTALITY; HUMAN; INCIDENCE; INFLUENZA; LENGTH OF STAY; MAJOR CLINICAL STUDY; MALE; MORBIDITY; MORTALITY; PRIORITY JOURNAL; SEX DIFFERENCE; CLINICAL TRIAL; COMPLICATION; FOLLOW UP; HOSPITAL PATIENT; HOSPITALIZATION; MULTICENTER STUDY; PROCEDURES; PROPENSITY SCORE; RETROSPECTIVE STUDY; RISK ASSESSMENT; RISK FACTOR; SURVIVAL RATE; UNITED STATES; VACCINATION;

AGED; FEMALE; FOLLOW-UP STUDIES; HEART FAILURE; HOSPITAL MORTALITY; HOSPITALIZATION; HUMANS; INCIDENCE; INFLUENZA, HUMAN; INPATIENTS; MALE; MORBIDITY; PROPENSITY SCORE; RETROSPECTIVE STUDIES; RISK ASSESSMENT; RISK FACTORS; SURVIVAL RATE; UNITED STATES; VACCINATION;

EID: 85060256194     PISSN: 22131779     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jchf.2018.10.011     Document Type: Article

References (18)

1. U.S. Centers for Disease Control and Prevention. Estimated Influenza Illnesses, Medical visits, and Hospitalizations Averted by Vaccination in the United States. Atlanta: CDC. Available at: https://www.cdc.gov/flu/about/disease/2016-17.htm Accessed July 22, 2018.
2. Sandoval, C., Walter, S.D., Krueger, P., et al. Risk of hospitalization during influenza season among a cohort of patients with congestive heart failure. Epidemiol Infect 135 (2007), 574–582.
3. Warren-gash, C., Smeeth, L., Hayward, A.C., Influenza as a trigger for acute myocardial infarction or death from cardiovascular disease: a systematic review. Lancet Infect Dis 9 (2009), 601–610.
4. Mozzafarian, D., Benjamin, E.J., Go, A.S., et al., for the American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Heart disease and stroke statistics—2016 update: a report from the American Heart Association. Circulation., 133, 2016, e38–e360.
5. Vardeny, O., Udell, J.A., Joseph, J., et al. High-dose influenza vaccine to reduce clinical outcomes in high-risk cardiovascular patients: rationale and design of the INVESTED trial. Am Heart J 202 (2018), 97–103.
6. Upshur, R.E., Goel, V., Measuring the impact of influenza on the hospital admission rates of the elderly in Ontario: a five-year admission rate analysis, 1988–1993. Can J Public Health 91 (2000), 144–147.
7. Stewart, S., Mcintyre, K., Capewell, S., Mcmurray, J.J., Heart failure in a cold climate. Seasonal variation in heart failure-related morbidity and mortality. J Am Coll Cardiol 39 (2002), 760–766.
8. Alon, D., Stein, G.Y., Korenfeld, R., Fuchs, S., Predictors and outcomes of infection-related hospital admissions of heart failure patients. PLoS One, 8, 2013, e72476.
9. Healthcare Cost and Utilization Project. National Inpatient Sample. HCUP. 2013–2014. Rockville, MD: Agency for Healthcare Research and Quality. Available at: www.hcup-us.ahrq.gov/nisoverview.jsp. Accessed July 22, 2018.
10. Bonow, R.O., Bennett, S., Casey, D.E. Jr., et al. ACC/AHA clinical performance measures for adults with chronic heart failure: a report of the American College of Cardiology/American Heart Association Task Force on Performance Measures (Writing Committee to Develop Heart Failure Clinical Performance Measures) endorsed by the Heart Failure Society of America. J Am Coll Cardiol 46 (2005), 1144–1178.
11. Khera, R., Angraal, S., Couch, T., et al. Adherence to methodological standards in research using the national inpatient sample. JAMA 318 (2017), 2011–2018.
12. Peter C. Austin, Using the standardized difference to compare the prevalence of a binary variable between two groups in observational research. Comm Stat 38 (2009), 1228–1234.
13. Fagnoul, D., Pasquier, P., Bodson, L., Ortiz, J.A., Vincent, J.L., De backer, D., Myocardial dysfunction during H1N1 influenza infection. J Crit Care 28 (2013), 321–327.
14. Clar, C., Oseni, Z., Flowers, N., Keshtkar-jahromi, M., Rees, K., Influenza vaccines for preventing cardiovascular disease. Cochrane Database Syst Rev, 2015, CD005050.
15. Vardeny, O., Claggett, B., Udell, J.A., et al. Influenza vaccination in patients with chronic heart failure: the PARADIGM-HF trial. J Am Coll Cardiol HF 4 (2016), 152–158.
16. Yancy, C.W., Jessup, M., Bozkurt, B., et al. 2013 ACCF/AHA guideline for the management of heart failure: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol 62 (2013), e147–e239.
17. Thickett, D.R., Moromizato, T., Litonjua, A.A., et al. Association between prehospital vitamin D status and incident acute respiratory failure in critically ill patients: a retrospective cohort study. BMJ Open Respir Res, 2, 2015, e000074.
18. Zhao, J.D., Jia, J.J., Dong, P.S., et al. Effect of vitamin D on ventricular remodelling in heart failure: a meta-analysis of randomised controlled trials. BMJ Open, 8, 2018, e020545.